Stuart Arbuckle
Chief Operating Officer bij VERTEX PHARMACEUTICALS INCORPORATED
Vermogen: 21 M $ op 31-03-2024
Profiel
De heer Stuart A. Arbuckle is Onafhankelijk Bestuurder bij Rhythm Pharmaceuticals, Inc., Onafhankelijk Bestuurder bij ImmunoGen, Inc. en Chief Operating Officer & Executive Vice President bij Vertex Pharmaceuticals, Inc. Hij zetelt in de Raad van Bestuur van Rhythm Pharmaceuticals, Inc., ImmunoGen, Inc., Biotechnology Innovation Organization en Cancer Support Community. De heer Arbuckle was voorheen werkzaam als Vice President & GM-Oncology Business Unit bij Amgen, Inc. en als Principal bij GlaxoSmithKline Plc. Hij was ook lid van de raad van bestuur van Cerulean Pharma, Inc. en Wellness Community. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Leeds.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
26-02-2024 | 49 831 ( 0.02% ) | 21 M $ | 31-03-2024 |
Actieve functies van Stuart Arbuckle
Bedrijven | Functie | Begin |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 01-02-2021 |
RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 24-07-2019 |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Director/Board Member | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Eerdere bekende functies van Stuart Arbuckle
Bedrijven | Functie | Einde |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12-02-2024 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 01-07-2017 |
AMGEN INC. | Corporate Officer/Principal | 01-08-2012 |
GSK PLC | Corporate Officer/Principal | - |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Director/Board Member | - |
Opleiding van Stuart Arbuckle
University of Leeds | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
AMGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Commercial Services |